Flying Eze and its trusted partners need your
permission to store and access cookies, unique identifiers, personal data, and information on your
browsing behaviour on this device. This only applies to Flying Eze. You don’t have to accept, and
you
can change your preferences at any time via the Privacy Options link at the bottom of this screen. If
you don’t accept, you may will still see some personalised ads and content.
Cookies, device identifiers, or other information can be stored or accessed on
your device for the purposes presented to you.
Ads and content can be personalised based on a profile. More data can be added
to better personalise ads and content. Ad and content performance can be
measured. Insights about audiences who saw the ads and content can be derived.
Data can be used to build or improve user experience, systems and software.
Precise geolocation and information about device characteristics can be used.
If you don’t want to accept, please select Read More option below where you can also see how and
why your data may be used. You can also see where we or our partners claim a legitimate interest and
object to the processing of your data.
The move is effective immediately, Health and Seniors Care Minister Heather Stefanson said in the release.
“Tens of thousands of doses of the AstraZeneca vaccine remain in clinics and pharmacies across the province, which is why we’re expanding the eligibility criteria for the vaccine,” said Stefanson.
“I want to thank physician and pharmacy partners for their work to provide vaccine and look forward to the numbers of doses administered increasing quickly over the coming days.”
Eligible Manitobans can find their nearest clinic or pharmacy with available doses by visiting the province’s website.
Up until now, the AstraZeneca vaccine in Manitoba had been available to those 65 and over, and to people between 55 and 64 with certain underlying medical conditions.
Health Canada has approved the vaccine for people under 55, but the National Advisory Committee on Immunization has recommended the shot only be offered to those 55 and older due to a slightly elevated risk of an extremely rare blood clot disorder.
There have been just two cases of blood clots in Canada out of the more than 700,00 doses of AstraZeneca administered so far.
“Based on all of the evidence available internationally to date, we continue to believe benefits of the AstraZeneca/ Covishield vaccine to protect against COVID-19 outweigh any potential risks,” said Dr. Joss Reimer, medical lead for the Vaccine Implementation Task Force.
“Expanding the criteria will help us reach more Manitobans, particularly those who may face challenges or face barriers in going to a super site or pop-up clinic.”
Manitoba’s premier and the province’s top doctor are expected to have more details at a COVID-19 update Monday.
Brian Pallister and Dr. Brent Roussin have scheduled a press conference for 12:30 p.m. Global News will stream the event live in this story.
Questions about COVID-19? Here are some things you need to know:
Symptoms can include fever, cough and difficulty breathing — very similar to a cold or flu. Some people can develop a more severe illness. People most at risk of this include older adults and people with severe chronic medical conditions like heart, lung or kidney disease. If you develop symptoms, contact public health authorities.
To prevent the virus from spreading, experts recommend frequent handwashing and coughing into your sleeve. They also recommend minimizing contact with others, staying home as much as possible and maintaining a distance of two metres from other people if you go out. In situations where you can’t keep a safe distance from others, public health officials recommend the use of a non-medical face mask or covering to prevent spreading the respiratory droplets that can carry the virus. In some provinces and municipalities across the country, masks or face coverings are now mandatory in indoor public spaces.